Regeneron to Report First Quarter 2016 Financial and Operating Results and Host Conference Call and Webcast on May 5, 2016

TARRYTOWN, N.Y.,April 15, 2016/PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) today announced that it will report its first quarter 2016 financial and operating results onThursday, May 5, 2016, before the U.S. financial markets open.  The Company will host a conference call and simultaneous webcast at8:30 AM Eastern Timethat day.

Conference Call InformationTo access this call, dial (888) 771-4371 (U.S.) or (847) 585-4405 (International).  A link to the webcast may be accessed from the 'Events and Presentations' page of Regeneron's website atwww.regeneron.com.  A replay of the conference call and webcast will be archived on the Company's website and will be available for 30 days.

About Regeneron Pharmaceuticals, Inc.Regeneron (NASDAQ:REGN) is a leading science-based biopharmaceutical company based inTarrytown, New Yorkthat discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron commercializes medicines for high LDL cholesterol, eye diseases, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including oncology, rheumatoid arthritis, asthma, atopic dermatitis, pain, and infectious diseases. For additional information about the company, please visitwww.regeneron.comor follow @Regeneron on Twitter.

Investor Relations

Corporate Communications

Manisha Narasimhan, Ph.D.

Hala Mirza

914.847.5126

914.847.3422

[email protected]

[email protected]